Claims
- 1. A pharmaceutical composition comprising PAF-AH enzyme and a pharmaceutically acceptable diluent, adjuvant or carrier.
- 2. A method for treating a mammal susceptible to or suffering from a PAF-mediated pathological condition comprising administering the pharmaceutical composition of claim 1 to said mammal in an amount sufficient to supplement endogenous PAF-AH activity and to inactivate pathological amounts of PAF in said mammal.
- 3. A method for treating a mammal susceptible to or suffering from pleurisy comprising administering the pharmaceutical composition of claim 1 to said mammal in an amount sufficient to supplement endogenous PAF-AH activity and to inactivate pathological amounts of PAF of said mammal.
- 4. A method for treating a mammal susceptible to or suffering from asthma comprising administering the pharmaceutical composition of claim 1 to said mammal in an amount sufficient to supplement endogenous PAF-AH activity and to inactivate pathological amounts of PAF of said mammal.
- 5. A method for treating a mammal susceptible to or suffering from rhinitis comprising administering the pharmaceutical composition of claim 1 to said mammal in an amount sufficient to supplement endogenous PAF-AH activity and to inactivate pathological amounts of PAF in said mammal.
- 6. A method for treating a mammal susceptible to or suffering from necrotizing enterocolitis comprising administering the pharmaceutical composition of claim 1 to said mammal in an amount sufficient to supplement endogenous PAF-AH activity and to inactivate pathological amounts of PAF in said mammal.
- 7. A method for treating a mammal susceptible to or suffering from acute respiratory distress syndrome comprising administering the pharmaceutical composition of claim 1 to said mammal in an amount sufficient to supplement endogenous PAF-AH activity and to inactivate pathological amounts of PAF in said mammal.
Parent Case Info
[0001] This application is a continuation-in-part of co-pending U.S. patent application Ser. No. 08/318,905 filed Oct. 6, 1994, which in turn is a continuation-in-part of co-pending U.S. patent application Ser. No. 08/133,803 filed Oct. 6, 1993.
Continuations (3)
|
Number |
Date |
Country |
Parent |
09577758 |
May 2000 |
US |
Child |
09729402 |
Dec 2000 |
US |
Parent |
09010715 |
Jan 1998 |
US |
Child |
09577758 |
May 2000 |
US |
Parent |
08480658 |
Jun 1995 |
US |
Child |
09010715 |
Jan 1998 |
US |
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
08318905 |
Oct 1994 |
US |
Child |
08480658 |
Jun 1995 |
US |
Parent |
08133803 |
Oct 1993 |
US |
Child |
08318905 |
Oct 1994 |
US |